CollPlant Biotechnologies Ltd. (CLGN) Investor Relations Documents

CollPlant Biotechnologies Ltd. (CLGN) investor relations documents from the company's IR site: 37 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-06-30Press releaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT
2026-05-29Press releaseCOLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
2026-04-13Press releaseCollPlant Issues Letter to Shareholders
2026-03-26Press releaseCOLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
2026-03-24Press releaseCollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
2026-03-18Press releaseCollPlant Biotechnologies Launches Redesigned Corporate Website
2026-03-11Press releaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
2026-02-26Press releaseCollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
2026-02-23Press releaseCollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
2026-02-17Press releaseCollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
Press releaseCollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17
Press releaseCollPlant to present at the Dawson James Small Cap Growth Conference on October 12
Press releaseCollPlant Announces Commercial Launch of BioInk Platform with Collink.3D™ for Use in 3D Bioprinting of Human Tissues, S
Press releaseCollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs
Quarterly reportCollPlant Biotechnologies Reports Third Quarter (Q3) 2020 Financial Results and Provides Business Update
Quarterly reportCollPlant Biotechnologies Reports Second Quarter (Q2) 2020 Financial Results
Quarterly reportCollPlant Biotechnologies Reports First Quarter (Q1) 2020 Financial Results
Press releaseCollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2020
Press releaseCollPlant To Present at the Aesthetics Innovation Summit 2022
Press releaseCollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results
Press releaseCollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results
Press releaseCollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million
Press releaseCollplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update
Press releaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Press releaseCollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results
Press releaseCollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results
Press releaseCollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results
Press releaseCOLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Press releaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Press releaseCollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
Press releaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Press releaseCollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
Press releaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Press releaseCollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update
Press releaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Press releaseCOLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
Press releaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CAL
Press releaseCOLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Press releaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Press releaseCOLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

CLGN overview · CLGN earnings · CLGN financials · CLGN KPIs · CLGN ownership · CLGN peers · CLGN filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.